Point72 Hong Kong’s Antares Pharma, Inc. ATRS Stock Holding History

Point72 Hong Kong’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,961	Closed	-$16K	–	2582
2022 Q1	$16K	Buy	+3,961	New	+$14.4K	﹤0.01%	1559
2021 Q2	–	Sell	-1,697	Closed	-$7K	–	2497
2021 Q1	$7K	Sell	1,697 -731	-30%	-$3.17K	﹤0.01%	1629
2020 Q4	$10K	Sell	2,428 -841	-26%	-$2.72K	﹤0.01%	1545
2020 Q3	$9K	Sell	3,269 -422	-11%	-$1.17K	﹤0.01%	1014
2020 Q2	$10K	Sell	3,691 -1,632	-31%	-$4.55K	﹤0.01%	987
2020 Q1	$13K	Sell	5,323 -6,677	-56%	-$22.7K	0.01%	637
2019 Q4	$56K	Buy	+12,000	New	+$49.1K	0.01%	661

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Point72 Hong Kong's ATRS Position: Q2 2022 in Review

Point72 Hong Kong sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,961 shares — an estimated $16K sold.

Point72 Hong Kong first reported a position in ATRS in Q4 2019 and held it in 7 quarters. The position peaked at $56K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Point72 Hong Kong reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 3,961 Antares Pharma, Inc. shares in Q2 2022, an estimated $16K.
Point72 Hong Kong first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 7 quarters.
Point72 Hong Kong's Antares Pharma, Inc. position peaked at $56K in Q4 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.